National Cancer Institute Initiative Confirms High Fidelity of Next-Generation Cancer Models
The National Cancer Institute (NCI) Human Cancer Models Initiative (HCMI) has confirmed that its next-generation patient-derived cancer models accurately reflect the biology of patient tumors. This initiative, established to improve the accuracy of laboratory models, has generated 665 models spanning 25 cancer types, including rare diseases. Each model is linked to comprehensive genomic, transcriptomic, and clinical data and is openly available to researchers globally. A recent study, involving a collaboration of research partners worldwide, analyzed 421 matched tumor-model pairs. The results showed 97.8% genetic concordance, 95% epigenomic concordance, and 92% transcriptional similarity between the models and their originating tumors. This high level of agreement across genetic, epigenomic, and transcriptional dimensions provides strong evidence that these models are not only genetically similar but also biologically representative of how tumors function. ATCC, the authorized provider of the collection, r...